UK markets close in 2 hours 5 minutes

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
15.98+0.36 (+2.30%)
At close: 04:00PM EST
16.24 +0.26 (+1.63%)
Pre-market: 09:22AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 9.05B
Enterprise value 22.16B
Trailing P/E 11.48
Forward P/E 9.69
PEG ratio (5-yr expected) 1.03
Price/sales (ttm)0.46
Price/book (mrq)0.58
Enterprise value/revenue 1.16
Enterprise value/EBITDA 6.40

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-47.47%
S&P500 52-week change 3-10.18%
52-week high 335.04
52-week low 312.79
50-day moving average 314.31
200-day moving average 323.41

Share statistics

Avg vol (3-month) 31.29M
Avg vol (10-day) 3800.69k
Shares outstanding 5586.83M
Implied shares outstanding 6N/A
Float 8535.78M
% held by insiders 10.00%
% held by institutions 16.89%
Shares short (14 Nov 2022) 41.39M
Short ratio (14 Nov 2022) 40.73
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 40.24%
Shares short (prior month 13 Oct 2022) 4493.8k

Dividends & splits

Forward annual dividend rate 40.71
Forward annual dividend yield 44.59%
Trailing annual dividend rate 31.35
Trailing annual dividend yield 38.64%
5-year average dividend yield 4N/A
Payout ratio 450.59%
Dividend date 326 May 2022
Ex-dividend date 412 May 2022
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 4.01%
Operating margin (ttm)7.67%

Management effectiveness

Return on assets (ttm)2.53%
Return on equity (ttm)6.66%

Income statement

Revenue (ttm)19.05B
Revenue per share (ttm)32.49
Quarterly revenue growth (yoy)14.70%
Gross profit (ttm)5.08B
EBITDA 2.41B
Net income avi to common (ttm)763.34M
Diluted EPS (ttm)1.36
Quarterly earnings growth (yoy)-15.70%

Balance sheet

Total cash (mrq)1.11B
Total cash per share (mrq)1.54
Total debt (mrq)13.79B
Total debt/equity (mrq)82.37
Current ratio (mrq)1.34
Book value per share (mrq)20.77

Cash flow statement

Operating cash flow (ttm)2.24B
Levered free cash flow (ttm)806.65M